Dr. De­braj Shome, Apollo Spec­tra Hos­pi­tals, Ban­ga­lore in­vents rev­o­lu­tion­ary hair re-growth for­mula, a first of its kind in In­dia

Business Sphere - - APOLLO HOSPITALS - By Our Cor­re­spon­dent

The rev­o­lu­tion­ary hair re­growth for­mula, QR 678 has shown ex­tra­or­di­nary hair re-growth re­sults in male & fe­male pat­tern bald­ness. QR 678 growth fac­tor for­mu­la­tion in­jec­tion ther­apy is an ad­vanced hair growth and anti-hair loss treat­ment which uses a mix­ture of sev­eral growth fac­tors to fa­cil­i­tate hair growth and pre­vent hair loss. The tech­nol­ogy re­cently bagged the pres­ti­gious hair re-growth patent from United States Patent & Trade­mark Of­fice (USPTO), for its physi­cian in­ven­tors Dr. De­braj Shome & Dr. Rinky Kapoor. QR 678, which is set to be made com­mer­cially avail­able in Tardeo and Chem­bur cen­ters of Apollo Spec­tra Hos­pi­tals, Mumbai, has al­ready picked up great at­ten­tion. Speak­ing about the lat­est in­ven­tion, Dr De­braj Shome, Apollo Spec­tra Hos­pi­tals said, "Our stud­ies in­di­cate 30 per­cent of men un­der 30 and 80 per­cent of men un­der 80 will wit­ness bald­ing. How­ever, these sta­tis­tics be­come worse with stress­ful life­styles, hor­mones and an­tibi­otics in food and a va­ri­ety of other pol­lu­tants that are dam­ag­ing peo­ple's bod­ies and their hair. Till date, hair trans­plant was thought to be the only so­lu­tion but that it­self is painful, needs to be re­peated and some­times may not work as well as one would ex­pect. The QR 678 in­jec­tion ther­apy is non-sur­gi­cal, much cheaper and has shown promis­ing re­sults, even in chemo­ther­apy in­duced hair fall, in cancer pa­tients".

Dr. De­braj Shome, Apollo Spec­tra Hos­pi­tals

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.